{"id":48075,"date":"2025-11-14T14:50:27","date_gmt":"2025-11-14T06:50:27","guid":{"rendered":"https:\/\/flcube.com\/?p=48075"},"modified":"2025-11-14T14:50:28","modified_gmt":"2025-11-14T06:50:28","slug":"pfizer-reduces-biontech-holding-by-54-7-while-collaboration-remains-intact","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=48075","title":{"rendered":"Pfizer Reduces BioNTech Holding by 54.7% While Collaboration Remains Intact"},"content":{"rendered":"\n<p><strong>Pfizer Inc.<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/PFE:NYSE\">NYSE: PFE<\/a>) disclosed on <strong>November\u202f13,\u202f2025<\/strong> that it has <strong>sold a portion of its equity stake<\/strong> in <strong>BioNTech SE<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/BNTX:NASDAQ\">NASDAQ: BNTX<\/a>). A regulatory filing shows the divestiture trimmed Pfizer\u2019s holding from roughly <strong>3.68\u202fmillion<\/strong> to <strong>1.66\u202fmillion<\/strong> sponsored American Depositary Shares (ADS), a <strong>54.7\u202f% reduction<\/strong> valued at <strong>\u2248\u202fUSD\u202f163.5\u202fmillion<\/strong> based on the September\u202f30,\u202f2025 closing price.<\/p>\n\n\n\n<p>BioNTech issued a statement confirming that the <strong>strategic partnership<\/strong> launched in 2018\u2014centered on the co\u2011development of <strong>mRNA\u2011based influenza vaccines<\/strong>\u2014<strong>remains unchanged<\/strong>. The company declined to comment on Pfizer\u2019s capital\u2011market actions.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-transaction-details\">Transaction Details<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Metric<\/th><th>Figure<\/th><\/tr><\/thead><tbody><tr><td><strong>Original Pfizer stake (pre\u2011sale)<\/strong><\/td><td>~3.68\u202fmillion ADS<\/td><\/tr><tr><td><strong>Post\u2011sale Pfizer stake<\/strong><\/td><td>~1.66\u202fmillion ADS<\/td><\/tr><tr><td><strong>Percentage sold<\/strong><\/td><td>54.7\u202f%<\/td><\/tr><tr><td><strong>Value of remaining stake<\/strong><\/td><td>USD\u202f163.5\u202fmillion (Sept\u202f30,\u202f2025)<\/td><\/tr><tr><td><strong>Primary collaboration<\/strong><\/td><td>mRNA influenza\u2011vaccine program (initiated 2018)<\/td><\/tr><tr><td><strong>Regulatory filing<\/strong><\/td><td>Form\u202f13F (SEC) &amp; German transparency register<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-rationale\">Strategic Rationale<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Capital allocation:<\/strong> Pfizer is reshaping its balance sheet after a multi\u2011year focus on core oncology, vaccines, and rare\u2011disease pipelines.<\/li>\n\n\n\n<li><strong>Liquidity generation:<\/strong> The sale frees <strong>\u2248\u202fUSD\u202f180\u202fmillion<\/strong> of cash, which can be redeployed toward <strong>late\u2011stage mRNA oncology candidates<\/strong> and <strong>next\u2011generation vaccine platforms<\/strong>.<\/li>\n\n\n\n<li><strong>Partnership continuity:<\/strong> Both parties stress that the <strong>research collaboration<\/strong>\u2014including joint clinical trials, shared mRNA technology, and co\u2011manufacturing agreements\u2014<strong>continues without interruption<\/strong>.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-reaction\">Market Reaction<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Pfizer stock:<\/strong> Opened <strong>+0.6\u202f%<\/strong> on the news, reflecting modest investor confidence that the divestiture is a routine portfolio adjustment.<\/li>\n\n\n\n<li><strong>BioNTech stock:<\/strong> Unchanged, as the market had already priced in the partnership\u2019s stability.<\/li>\n\n\n\n<li><strong>Sector outlook:<\/strong> The move underscores a broader trend of <strong>large pharma firms monetizing non\u2011core equity positions<\/strong> while preserving <strong>high\u2011value R&amp;D alliances<\/strong> in the mRNA space.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-forward-looking-statements\">Forward\u2011Looking Statements<\/h3>\n\n\n\n<p>This brief contains forward\u2011looking statements regarding Pfizer\u2019s capital\u2011allocation strategy, the ongoing BioNTech collaboration, and market expectations. Actual results may differ due to regulatory outcomes, clinical trial progress, and broader macro\u2011economic conditions.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pfizer Inc. (NYSE: PFE) disclosed on November\u202f13,\u202f2025 that it has sold a portion of its&#8230;<\/p>\n","protected":false},"author":1,"featured_media":48077,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[342,30,20,1124,863,309],"class_list":["post-48075","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-biontech","tag-biotech","tag-finance","tag-nasdaq-bntx","tag-nyse-pfe","tag-pfizer"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Pfizer Reduces BioNTech Holding by 54.7% While Collaboration Remains Intact - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Pfizer Inc. (NYSE: PFE) disclosed on November\u202f13,\u202f2025 that it has sold a portion of its equity stake in BioNTech SE (NASDAQ: BNTX). A regulatory filing shows the divestiture trimmed Pfizer\u2019s holding from roughly 3.68\u202fmillion to 1.66\u202fmillion sponsored American Depositary Shares (ADS), a 54.7\u202f% reduction valued at \u2248\u202fUSD\u202f163.5\u202fmillion based on the September\u202f30,\u202f2025 closing price.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=48075\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pfizer Reduces BioNTech Holding by 54.7% While Collaboration Remains Intact\" \/>\n<meta property=\"og:description\" content=\"Pfizer Inc. (NYSE: PFE) disclosed on November\u202f13,\u202f2025 that it has sold a portion of its equity stake in BioNTech SE (NASDAQ: BNTX). A regulatory filing shows the divestiture trimmed Pfizer\u2019s holding from roughly 3.68\u202fmillion to 1.66\u202fmillion sponsored American Depositary Shares (ADS), a 54.7\u202f% reduction valued at \u2248\u202fUSD\u202f163.5\u202fmillion based on the September\u202f30,\u202f2025 closing price.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=48075\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-14T06:50:27+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-14T06:50:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1303-1.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=48075#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=48075\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Pfizer Reduces BioNTech Holding by 54.7% While Collaboration Remains Intact\",\"datePublished\":\"2025-11-14T06:50:27+00:00\",\"dateModified\":\"2025-11-14T06:50:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=48075\"},\"wordCount\":314,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=48075#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/1303-1.webp\",\"keywords\":[\"BioNTech\",\"Biotech\",\"Finance\",\"NASDAQ: BNTX\",\"NYSE: PFE\",\"Pfizer\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=48075#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=48075\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=48075\",\"name\":\"Pfizer Reduces BioNTech Holding by 54.7% While Collaboration Remains Intact - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=48075#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=48075#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/1303-1.webp\",\"datePublished\":\"2025-11-14T06:50:27+00:00\",\"dateModified\":\"2025-11-14T06:50:28+00:00\",\"description\":\"Pfizer Inc. (NYSE: PFE) disclosed on November\u202f13,\u202f2025 that it has sold a portion of its equity stake in BioNTech SE (NASDAQ: BNTX). A regulatory filing shows the divestiture trimmed Pfizer\u2019s holding from roughly 3.68\u202fmillion to 1.66\u202fmillion sponsored American Depositary Shares (ADS), a 54.7\u202f% reduction valued at \u2248\u202fUSD\u202f163.5\u202fmillion based on the September\u202f30,\u202f2025 closing price.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=48075#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=48075\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=48075#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/1303-1.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/1303-1.webp\",\"width\":1080,\"height\":608,\"caption\":\"Pfizer Reduces BioNTech Holding by 54.7% While Collaboration Remains Intact\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=48075#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pfizer Reduces BioNTech Holding by 54.7% While Collaboration Remains Intact\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pfizer Reduces BioNTech Holding by 54.7% While Collaboration Remains Intact - Insight, China&#039;s Pharmaceutical Industry","description":"Pfizer Inc. (NYSE: PFE) disclosed on November\u202f13,\u202f2025 that it has sold a portion of its equity stake in BioNTech SE (NASDAQ: BNTX). A regulatory filing shows the divestiture trimmed Pfizer\u2019s holding from roughly 3.68\u202fmillion to 1.66\u202fmillion sponsored American Depositary Shares (ADS), a 54.7\u202f% reduction valued at \u2248\u202fUSD\u202f163.5\u202fmillion based on the September\u202f30,\u202f2025 closing price.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=48075","og_locale":"en_US","og_type":"article","og_title":"Pfizer Reduces BioNTech Holding by 54.7% While Collaboration Remains Intact","og_description":"Pfizer Inc. (NYSE: PFE) disclosed on November\u202f13,\u202f2025 that it has sold a portion of its equity stake in BioNTech SE (NASDAQ: BNTX). A regulatory filing shows the divestiture trimmed Pfizer\u2019s holding from roughly 3.68\u202fmillion to 1.66\u202fmillion sponsored American Depositary Shares (ADS), a 54.7\u202f% reduction valued at \u2248\u202fUSD\u202f163.5\u202fmillion based on the September\u202f30,\u202f2025 closing price.","og_url":"https:\/\/flcube.com\/?p=48075","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-11-14T06:50:27+00:00","article_modified_time":"2025-11-14T06:50:28+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1303-1.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=48075#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=48075"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Pfizer Reduces BioNTech Holding by 54.7% While Collaboration Remains Intact","datePublished":"2025-11-14T06:50:27+00:00","dateModified":"2025-11-14T06:50:28+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=48075"},"wordCount":314,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=48075#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1303-1.webp","keywords":["BioNTech","Biotech","Finance","NASDAQ: BNTX","NYSE: PFE","Pfizer"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=48075#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=48075","url":"https:\/\/flcube.com\/?p=48075","name":"Pfizer Reduces BioNTech Holding by 54.7% While Collaboration Remains Intact - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=48075#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=48075#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1303-1.webp","datePublished":"2025-11-14T06:50:27+00:00","dateModified":"2025-11-14T06:50:28+00:00","description":"Pfizer Inc. (NYSE: PFE) disclosed on November\u202f13,\u202f2025 that it has sold a portion of its equity stake in BioNTech SE (NASDAQ: BNTX). A regulatory filing shows the divestiture trimmed Pfizer\u2019s holding from roughly 3.68\u202fmillion to 1.66\u202fmillion sponsored American Depositary Shares (ADS), a 54.7\u202f% reduction valued at \u2248\u202fUSD\u202f163.5\u202fmillion based on the September\u202f30,\u202f2025 closing price.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=48075#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=48075"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=48075#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1303-1.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1303-1.webp","width":1080,"height":608,"caption":"Pfizer Reduces BioNTech Holding by 54.7% While Collaboration Remains Intact"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=48075#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Pfizer Reduces BioNTech Holding by 54.7% While Collaboration Remains Intact"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1303-1.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/48075","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=48075"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/48075\/revisions"}],"predecessor-version":[{"id":48078,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/48075\/revisions\/48078"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/48077"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=48075"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=48075"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=48075"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}